Ειδήσεις: CANCER THERAPY | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

31/03 14:00 foxnews.com

Common blood pressure pill could make certain cancer treatments more powerful

telmisartan olaparib cancer therapy hypertension drug DNA damage immune response

29/03 23:46 yahoo.com

Why Allogene Therapeutics (ALLO) Says Its Lead Cancer Program Is Still on Track in 2026

Allogene Therapeutics cancer therapy 2026 preclinical data clinical trials regulatory strategy

26/03 00:37 yahoo.com

Thermo Fisher Scientific (TMO) Partners With AIM ImmunoTech on Phase 3 Cancer Trial

Thermo Fisher Scientific AIM ImmunoTech Phase 3 trial cancer therapy clinical partnership oncology research

24/03 19:32 yahoo.com

Gilead acquires first TCE asset with $2.2bn Ouro Medicines buyout

Gilead Ouro Medicines acquisition targeted cancer therapy oncology $2.2 billion

24/03 16:53 google.com

ImmunityBio shares fall on FDA warning letter over cancer therapy claims in ad - Reuters

ImmunityBio FDA warning cancer therapy stock decline advertising claims biotech

24/03 16:53 google.com

ImmunityBio shares fall on FDA warning letter over cancer therapy claims in ad - Reuters

ImmunityBio FDA warning cancer therapy stock decline advertising claims biotech

Loading...